+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bromhidrosis Disease Treatment Market - Global Forecast 2026-2032- Product Image
Bromhidrosis Disease Treatment Market - Global Forecast 2026-2032- Product Image
New

Bromhidrosis Disease Treatment Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 196 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6011459
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The bromhidrosis disease treatment market is navigating increasing clinical complexity and shifting patient expectations, driving significant changes for innovators, healthcare providers, and commercial organizations. Advances in personalized care, evolving procurement strategies, and technological innovation continue to reshape competitive dynamics and decision-making frameworks across the sector.

Market Snapshot

The bromhidrosis disease treatment market expanded from USD 536.67 million in 2025 to USD 581.80 million in 2026 and is on pace to achieve USD 1.02 billion by 2032, reflecting a CAGR of 9.71%. Heightened awareness of patient quality-of-life concerns, increased demand for minimally invasive procedures, and evolving reimbursement landscapes are central forces shaping growth opportunities. Stakeholders are responding to clinical and operational barriers as they optimize treatment delivery, supply resilience, and care access within a rapidly developing therapeutic environment.

Bromhidrosis Disease Treatment Market: Scope & Segmentation

  • Product Types: Antiperspirants, botulinum toxin, iontophoresis, and surgical options rank as core treatment categories. Each delivers unique efficacy profiles, mechanisms of action, and preference alignment for patients and providers.
  • Formulation Differences: Within antiperspirants, formats such as creams, roll-ons, sprays, and sticks present different trade-offs in convenience, adherence, and patient tolerability. Botulinum toxin options further differentiate on molecule type, dosing regimen, and familiarity among clinicians.
  • Administration Routes: Topical and injectable options span cream, gel, roll-on, spray, intradermal, and subcutaneous administration. Delivery mode impacts practitioner skill requirements, patient comfort, and frequency of use.
  • Distribution Channels: E-commerce platforms, hospital pharmacy, retail pharmacy, and specialty clinics represent the primary pathways for therapy access. Channel choice impacts care availability, clinician oversight, and pricing transparency.
  • End-User Settings: Care is distributed via dermatology clinics (sorted between chain and independent clinics), hospitals (public and private), and home care environments. These end points influence procurement frameworks, referral networks, and scale efficiencies.
  • Regional Coverage: Americas, Europe, Middle East & Africa, and Asia-Pacific all display unique adoption patterns, regulatory challenges, and commercial models based on local payer systems, urbanization levels, and infrastructure maturity.

Key Takeaways

  • Strategic decision-making is shaped by diverse treatment mechanisms, patient support needs, and channel strategies to enhance adoption and long-term adherence.
  • Technological advances in device design and biologics are expanding care choices and necessitating multidisciplinary operational models across clinical settings.
  • Evolving patient expectations for discreet and durable solutions are prompting providers to integrate psychosocial support with physiological intervention.
  • Regional differences demand tailored evidence generation, stakeholder engagement, and supply chain configuration to address fragmented regulations and payer priorities.
  • Successful commercialization increasingly hinges on coordinated clinician education, robust partnership models, and investment in real-world evidence to guide adoption and drive sustainable growth.

Tariff Impact on Bromhidrosis Disease Treatment Market

Recent tariff policy shifts in the United States have directly affected the cost structure and supply chain performance of imported devices, biologics, and consumables used in bromhidrosis therapy. Health systems and suppliers are mitigating cost fluctuations through strategic sourcing, nearshoring, and flexible supplier agreements. As providers prioritize continuity and cost predictability, organizations investing in procurement resilience are best positioned to maintain stable therapy access and business performance.

Research Methodology & Data Sources

Market insights stem from systematic reviews of clinical literature, regulatory filings, and device approvals, reinforced by in-depth interviews with clinicians, procurement managers, and industry experts. Triangulation with peer-reviewed studies and clinical guidelines enables balanced interpretation, while iterative expert validation confirms actionable conclusions and minimizes bias.

Why This Bromhidrosis Disease Treatment Market Report Matters

  • Equips leaders with actionable segmentation and competitive intelligence to refine product development and channel strategies in diverse markets.
  • Clarifies the operational and policy factors influencing patient access, supply chain risk, and regional growth opportunities.
  • Supports evidence-based decision-making with a transparent, reproducible methodology tailored to real-world clinical priorities.

Conclusion

Collaborative action, informed by robust evidence and practical segmentation insights, is essential to advance bromhidrosis care and commercial resilience. Aligning clinical innovation with evolving regional and operational realities will empower stakeholders to deliver meaningful improvements in patient experience and organizational performance.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Bromhidrosis Disease Treatment Market, by Product Type
8.1. Antiperspirants
8.1.1. Cream
8.1.2. Roll-On
8.1.3. Spray
8.1.4. Stick
8.2. Botulinum Toxin
8.2.1. AbobotulinumtoxinA
8.2.2. IncobotulinumtoxinA
8.2.3. OnabotulinumtoxinA
8.3. Iontophoresis
8.3.1. Portable Devices
8.3.2. Stationary Devices
8.4. Surgery
8.4.1. Curettage
8.4.2. Endoscopic Thoracic Sympathectomy
8.4.3. Local Excision
9. Bromhidrosis Disease Treatment Market, by Mode Of Administration
9.1. Injectable
9.1.1. Intradermal
9.1.2. Subcutaneous
9.2. Topical
9.2.1. Cream
9.2.2. Gel
9.2.3. Roll-On
9.2.4. Spray
10. Bromhidrosis Disease Treatment Market, by End User
10.1. Dermatology Clinics
10.1.1. Chain Clinics
10.1.2. Independent Clinics
10.2. Home Care
10.3. Hospitals
10.3.1. Private Hospitals
10.3.2. Public Hospitals
11. Bromhidrosis Disease Treatment Market, by Distribution Channel
11.1. E-Commerce
11.2. Hospital Pharmacy
11.3. Retail Pharmacy
12. Bromhidrosis Disease Treatment Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Bromhidrosis Disease Treatment Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Bromhidrosis Disease Treatment Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States Bromhidrosis Disease Treatment Market
16. China Bromhidrosis Disease Treatment Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. AbbVie Inc.
17.6. Allergan plc
17.7. Almirall, S.A.
17.8. Bausch Health Companies Inc.
17.9. Biovencer Healthcare Pvt. Ltd.
17.10. Celgene Corporation
17.11. Cutera, Inc.
17.12. Galderma SA
17.13. GlaxoSmithKline plc
17.14. Hikma Pharmaceuticals Plc
17.15. Ipsen Pharma
17.16. Johnson & Johnson Services, Inc.
17.17. Journey Medical Corporation
17.18. Leo Pharma A/S
17.19. Medytox, Inc.
17.20. Merck & Co., Inc.
17.21. Merz Pharma GmbH & Co. KGaA
17.22. Miramar Labs, Inc.
17.23. Novartis AG
17.24. Pfizer Inc.
17.25. Regeneron Pharmaceuticals, Inc.
17.26. Valeant Pharmaceuticals International, Inc.
List of Figures
FIGURE 1. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY MODE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY ANTIPERSPIRANTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY ANTIPERSPIRANTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY ANTIPERSPIRANTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY ANTIPERSPIRANTS, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY CREAM, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY CREAM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY CREAM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY ROLL-ON, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY ROLL-ON, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY ROLL-ON, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY SPRAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY SPRAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY SPRAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY STICK, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY STICK, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY STICK, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY BOTULINUM TOXIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY BOTULINUM TOXIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY BOTULINUM TOXIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY BOTULINUM TOXIN, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY ABOBOTULINUMTOXINA, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY ABOBOTULINUMTOXINA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY ABOBOTULINUMTOXINA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INCOBOTULINUMTOXINA, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INCOBOTULINUMTOXINA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INCOBOTULINUMTOXINA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY ONABOTULINUMTOXINA, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY ONABOTULINUMTOXINA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY ONABOTULINUMTOXINA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY IONTOPHORESIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY IONTOPHORESIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY IONTOPHORESIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY IONTOPHORESIS, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY PORTABLE DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY PORTABLE DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY PORTABLE DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY STATIONARY DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY STATIONARY DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY STATIONARY DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY SURGERY, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY SURGERY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY SURGERY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY CURETTAGE, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY CURETTAGE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY CURETTAGE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY ENDOSCOPIC THORACIC SYMPATHECTOMY, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY ENDOSCOPIC THORACIC SYMPATHECTOMY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY ENDOSCOPIC THORACIC SYMPATHECTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY LOCAL EXCISION, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY LOCAL EXCISION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY LOCAL EXCISION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INJECTABLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INJECTABLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INTRADERMAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INTRADERMAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INTRADERMAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY SUBCUTANEOUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY SUBCUTANEOUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TOPICAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TOPICAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TOPICAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY CREAM, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY CREAM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY CREAM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY GEL, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY GEL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY GEL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY ROLL-ON, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY ROLL-ON, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY ROLL-ON, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY SPRAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY SPRAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY SPRAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY DERMATOLOGY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY DERMATOLOGY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY DERMATOLOGY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY DERMATOLOGY CLINICS, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY CHAIN CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY CHAIN CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY CHAIN CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDEPENDENT CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDEPENDENT CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDEPENDENT CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY E-COMMERCE, BY REGION, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY E-COMMERCE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY E-COMMERCE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 117. AMERICAS BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 118. AMERICAS BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 119. AMERICAS BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY ANTIPERSPIRANTS, 2018-2032 (USD MILLION)
TABLE 120. AMERICAS BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY BOTULINUM TOXIN, 2018-2032 (USD MILLION)
TABLE 121. AMERICAS BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY IONTOPHORESIS, 2018-2032 (USD MILLION)
TABLE 122. AMERICAS BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY SURGERY, 2018-2032 (USD MILLION)
TABLE 123. AMERICAS BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 124. AMERICAS BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 125. AMERICAS BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 126. AMERICAS BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 127. AMERICAS BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY DERMATOLOGY CLINICS, 2018-2032 (USD MILLION)
TABLE 128. AMERICAS BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 129. AMERICAS BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 130. NORTH AMERICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 131. NORTH AMERICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 132. NORTH AMERICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY ANTIPERSPIRANTS, 2018-2032 (USD MILLION)
TABLE 133. NORTH AMERICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY BOTULINUM TOXIN, 2018-2032 (USD MILLION)
TABLE 134. NORTH AMERICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY IONTOPHORESIS, 2018-2032 (USD MILLION)
TABLE 135. NORTH AMERICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY SURGERY, 2018-2032 (USD MILLION)
TABLE 136. NORTH AMERICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 137. NORTH AMERICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 138. NORTH AMERICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 139. NORTH AMERICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 140. NORTH AMERICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY DERMATOLOGY CLINICS, 2018-2032 (USD MILLION)
TABLE 141. NORTH AMERICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 142. NORTH AMERICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 143. LATIN AMERICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 144. LATIN AMERICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 145. LATIN AMERICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY ANTIPERSPIRANTS, 2018-2032 (USD MILLION)
TABLE 146. LATIN AMERICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY BOTULINUM TOXIN, 2018-2032 (USD MILLION)
TABLE 147. LATIN AMERICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY IONTOPHORESIS, 2018-2032 (USD MILLION)
TABLE 148. LATIN AMERICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY SURGERY, 2018-2032 (USD MILLION)
TABLE 149. LATIN AMERICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 150. LATIN AMERICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 151. LATIN AMERICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 152. LATIN AMERICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 153. LATIN AMERICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY DERMATOLOGY CLINICS, 2018-2032 (USD MILLION)
TABLE 154. LATIN AMERICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 155. LATIN AMERICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY ANTIPERSPIRANTS, 2018-2032 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY BOTULINUM TOXIN, 2018-2032 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY IONTOPHORESIS, 2018-2032 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY SURGERY, 2018-2032 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY DERMATOLOGY CLINICS, 2018-2032 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 169. EUROPE BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 170. EUROPE BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 171. EUROPE BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY ANTIPERSPIRANTS, 2018-2032 (USD MILLION)
TABLE 172. EUROPE BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY BOTULINUM TOXIN, 2018-2032 (USD MILLION)
TABLE 173. EUROPE BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY IONTOPHORESIS, 2018-2032 (USD MILLION)
TABLE 174. EUROPE BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY SURGERY, 2018-2032 (USD MILLION)
TABLE 175. EUROPE BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 176. EUROPE BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 177. EUROPE BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 178. EUROPE BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 179. EUROPE BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY DERMATOLOGY CLINICS, 2018-2032 (USD MILLION)
TABLE 180. EUROPE BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 181. EUROPE BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 182. MIDDLE EAST BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 183. MIDDLE EAST BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 184. MIDDLE EAST BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY ANTIPERSPIRANTS, 2018-2032 (USD MILLION)
TABLE 185. MIDDLE EAST BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY BOTULINUM TOXIN, 2018-2032 (USD MILLION)
TABLE 186. MIDDLE EAST BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY IONTOPHORESIS, 2018-2032 (USD MILLION)
TABLE 187. MIDDLE EAST BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY SURGERY, 2018-2032 (USD MILLION)
TABLE 188. MIDDLE EAST BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 189. MIDDLE EAST BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 190. MIDDLE EAST BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 191. MIDDLE EAST BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 192. MIDDLE EAST BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY DERMATOLOGY CLINICS, 2018-2032 (USD MILLION)
TABLE 193. MIDDLE EAST BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 194. MIDDLE EAST BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 195. AFRICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 196. AFRICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 197. AFRICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY ANTIPERSPIRANTS, 2018-2032 (USD MILLION)
TABLE 198. AFRICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY BOTULINUM TOXIN, 2018-2032 (USD MILLION)
TABLE 199. AFRICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY IONTOPHORESIS, 2018-2032 (USD MILLION)
TABLE 200. AFRICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY SURGERY, 2018-2032 (USD MILLION)
TABLE 201. AFRICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 202. AFRICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 203. AFRICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 204. AFRICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 205. AFRICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY DERMATOLOGY CLINICS, 2018-2032 (USD MILLION)
TABLE 206. AFRICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 207. AFRICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 208. ASIA-PACIFIC BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 209. ASIA-PACIFIC BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 210. ASIA-PACIFIC BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY ANTIPERSPIRANTS, 2018-2032 (USD MILLION)
TABLE 211. ASIA-PACIFIC BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY BOTULINUM TOXIN, 2018-2032 (USD MILLION)
TABLE 212. ASIA-PACIFIC BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY IONTOPHORESIS, 2018-2032 (USD MILLION)
TABLE 213. ASIA-PACIFIC BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY SURGERY, 2018-2032 (USD MILLION)
TABLE 214. ASIA-PACIFIC BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 215. ASIA-PACIFIC BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 216. ASIA-PACIFIC BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 217. ASIA-PACIFIC BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 218. ASIA-PACIFIC BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY DERMATOLOGY CLINICS, 2018-2032 (USD MILLION)
TABLE 219. ASIA-PACIFIC BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 220. ASIA-PACIFIC BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 221. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 222. ASEAN BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 223. ASEAN BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 224. ASEAN BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY ANTIPERSPIRANTS, 2018-2032 (USD MILLION)
TABLE 225. ASEAN BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY BOTULINUM TOXIN, 2018-2032 (USD MILLION)
TABLE 226. ASEAN BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY IONTOPHORESIS, 2018-2032 (USD MILLION)
TABLE 227. ASEAN BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY SURGERY, 2018-2032 (USD MILLION)
TABLE 228. ASEAN BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 229. ASEAN BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 230. ASEAN BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 231. ASEAN BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 232. ASEAN BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY DERMATOLOGY CLINICS, 2018-2032 (USD MILLION)
TABLE 233. ASEAN BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 234. ASEAN BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 235. GCC BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 236. GCC BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 237. GCC BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY ANTIPERSPIRANTS, 2018-2032 (USD MILLION)
TABLE 238. GCC BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY BOTULINUM TOXIN, 2018-2032 (USD MILLION)
TABLE 239. GCC BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY IONTOPHORESIS, 2018-2032 (USD MILLION)
TABLE 240. GCC BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY SURGERY, 2018-2032 (USD MILLION)
TABLE 241. GCC BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 242. GCC BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 243. GCC BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 244. GCC BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 245. GCC BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY DERMATOLOGY CLINICS, 2018-2032 (USD MILLION)
TABLE 246. GCC BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 247. GCC BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 248. EUROPEAN UNION BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 249. EUROPEAN UNION BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 250. EUROPEAN UNION BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY ANTIPERSPIRANTS, 2018-2032 (USD MILLION)
TABLE 251. EUROPEAN UNION BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY BOTULINUM TOXIN, 2018-2032 (USD MILLION)
TABLE 252. EUROPEAN UNION BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY IONTOPHORESIS, 2018-2032 (USD MILLION)
TABLE 253. EUROPEAN UNION BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY SURGERY, 2018-2032 (USD MILLION)
TABLE 254. EUROPEAN UNION BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 255. EUROPEAN UNION BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 256. EUROPEAN UNION BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 257. EUROPEAN UNION BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 258. EUROPEAN UNION BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY DERMATOLOGY CLINICS, 2018-2032 (USD MILLION)
TABLE 259. EUROPEAN UNION BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 260. EUROPEAN UNION BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 261. BRICS BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 262. BRICS BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 263. BRICS BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY ANTIPERSPIRANTS, 2018-2032 (USD MILLION)
TABLE 264. BRICS BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY BOTULINUM TOXIN, 2018-2032 (USD MILLION)
TABLE 265. BRICS BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY IONTOPHORESIS, 2018-2032 (USD MILLION)
TABLE 266. BRICS BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY SURGERY, 2018-2032 (USD MILLION)
TABLE 267. BRICS BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 268. BRICS BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 269. BRICS BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 270. BRICS BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 271. BRICS BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY DERMATOLOGY CLINICS, 2018-2032 (USD MILLION)
TABLE 272. BRICS BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 273. BRICS BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 274. G7 BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 275. G7 BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 276. G7 BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY ANTIPERSPIRANTS, 2018-2032 (USD MILLION)
TABLE 277. G7 BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY BOTULINUM TOXIN, 2018-2032 (USD MILLION)
TABLE 278. G7 BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY IONTOPHORESIS, 2018-2032 (USD MILLION)
TABLE 279. G7 BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY SURGERY, 2018-2032 (USD MILLION)
TABLE 280. G7 BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 281. G7 BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 282. G7 BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 283. G7 BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 284. G7 BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY DERMATOLOGY CLINICS, 2018-2032 (USD MILLION)
TABLE 285. G7 BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 286. G7 BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 287. NATO BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 288. NATO BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 289. NATO BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY ANTIPERSPIRANTS, 2018-2032 (USD MILLION)
TABLE 290. NATO BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY BOTULINUM TOXIN, 2018-2032 (USD MILLION)
TABLE 291. NATO BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY IONTOPHORESIS, 2018-2032 (USD MILLION)
TABLE 292. NATO BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY SURGERY, 2018-2032 (USD MILLION)
TABLE 293. NATO BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 294. NATO BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 295. NATO BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 296. NATO BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 297. NATO BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY DERMATOLOGY CLINICS, 2018-2032 (USD MILLION)
TABLE 298. NATO BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 299. NATO BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 300. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 301. UNITED STATES BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 302. UNITED STATES BR

Companies Mentioned

The key companies profiled in this Bromhidrosis Disease Treatment market report include:
  • AbbVie Inc.
  • Allergan plc
  • Almirall, S.A.
  • Bausch Health Companies Inc.
  • Biovencer Healthcare Pvt. Ltd.
  • Celgene Corporation
  • Cutera, Inc.
  • Galderma SA
  • GlaxoSmithKline plc
  • Hikma Pharmaceuticals Plc
  • Ipsen Pharma
  • Johnson & Johnson Services, Inc.
  • Journey Medical Corporation
  • Leo Pharma A/S
  • Medytox, Inc.
  • Merck & Co., Inc.
  • Merz Pharma GmbH & Co. KGaA
  • Miramar Labs, Inc.
  • Novartis AG
  • Pfizer Inc.
  • Regeneron Pharmaceuticals, Inc.
  • Valeant Pharmaceuticals International, Inc.

Table Information

Report AttributeDetails
No. of Pages196
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 581.8 Million
Forecasted Market Value ( USD ) by 2032 $ 1020 Million
Compound Annual Growth Rate9.7%
Regions CoveredGlobal
No. of Companies Mentioned23

Related Topics

Related Reports

Bromhidrosis Disease Treatment - Global Strategic Business Report - Product Image

Bromhidrosis Disease Treatment - Global Strategic Business Report

  • Report
  • 224 Pages
  • Global
From
Gaucher Disease Treatment Market - Global Forecast 2026-2032 - Product Image

Gaucher Disease Treatment Market - Global Forecast 2026-2032

  • Report
  • 191 Pages
  • Global
From
Krabbe Disease Treatment Market - Global Forecast 2026-2032 - Product Image

Krabbe Disease Treatment Market - Global Forecast 2026-2032

  • Report
  • 192 Pages
  • Global
From
Axillary Hyperhidrosis - Market Insights, Epidemiology, and Market Forecast - 2034 - Product Image

Axillary Hyperhidrosis - Market Insights, Epidemiology, and Market Forecast - 2034

  • Report
  • 200 Pages
  • Global
From
Tay-Sachs Disease Market Report and Forecast 2025-2034 - Product Image

Tay-Sachs Disease Market Report and Forecast 2025-2034

  • Report
  • 350 Pages
  • Global
From

About the Bromhidrosis Disease Drug Market

Bromhidrosis Disease is a condition characterized by an unpleasant body odor caused by excessive sweating. It is classified as an endocrine and metabolic disorder, and is treated with drugs that target the underlying cause of the condition. These drugs are typically used to reduce the production of sweat, regulate hormones, and reduce inflammation. Commonly prescribed drugs include anticholinergics, antiperspirants, and topical corticosteroids. In some cases, oral medications such as antibiotics and antifungals may be prescribed. The Bromhidrosis Disease Drug market is a specialized segment of the Endocrine and Metabolic Disorders Drugs market. It is composed of a variety of drugs used to treat the condition, including anticholinergics, antiperspirants, topical corticosteroids, antibiotics, and antifungals. These drugs are typically prescribed by dermatologists and endocrinologists. Some companies in the Bromhidrosis Disease Drug market include GlaxoSmithKline, Pfizer, Merck, and Novartis. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.